1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008 [ J ]. CA Cancer J Clin, 2008,58:71 -96.
2O'Connell JB, Maggard MA, Ko CY. Colon cancer'survival rates with the new American Joint Committee on Cancer sixth edition staging[ J ]. J Natl Cancer lnst, 2004, 96 : 1420 - 1425.
3Popat S, Houlston RS. A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis [ J ]. Eur J Cancer, 2005, 41 : 2060 - 2070.
4Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer [J]. N Engl J Med, 2000, 342:69-77.
5Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: symtematic review[ J ]. J Natl Cancer lnst, 2007, 99:433 - 441.
6Meyerhardt JA, Tepper JE, Niedzwiecki D,et al. Impact of hospital procedure volume on surgical operation and long-term outcomes in highrisk curatively resected rectal cancer: findings from the Intergroup 0114 Study [ J ]. J Clin Oncol, 2004, 22:166-174
7Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellituson outcomes in patients with colon cancer[ J]. J Clin Oncol, 2003, 21:433-440.
8Meyerhardt JA, Catalano PJ, Hailer DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma[ J ]. Cancer, 2003, 98:484 - 495.
9Hailer DG, Catalano PJ, Macdonald JS,et al. Fluorouracil,Leucovorin and Levamisole adjuvant therapy for colon cancer: fiveyear final report of 1NT-0089 [ J]. Prog Proc Am Soc Clin Oncol, 1998, 17:256a.
10Andre T,Boni C,Mounedji-Boudiafl, et al. Oxaliplatin fluorouracil, and leucnvorin as adjuvant treatment for colon cancer [ J ]. N Engl J Med, 2004, 350:2340 -2351.
